161 related articles for article (PubMed ID: 11341669)
1. Double-blind, placebo-controlled trial of famotidine in children with abdominal pain and dyspepsia: global and quantitative assessment.
See MC; Birnbaum AH; Schechter CB; Goldenberg MM; Benkov KJ
Dig Dis Sci; 2001 May; 46(5):985-92. PubMed ID: 11341669
[TBL] [Abstract][Full Text] [Related]
2. Randomized, double-blind, placebo-controlled crossover trial of famotidine in patients with functional dyspepsia.
Kato M; Watanabe M; Konishi S; Kudo M; Konno J; Meguro T; Kitamori S; Nakagawa S; Shimizu Y; Takeda H; Asaka M
Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():27-31. PubMed ID: 15943843
[TBL] [Abstract][Full Text] [Related]
3. Histamine-2 Receptor Antagonist Cannot Prevent Recurrent Peptic Ulcers in Patients With Atherosclerotic Diseases Who Receive Platelet ADP Receptor Antagonist Monotherapy: A Randomized-Controlled, Double-Blind, and Double-Dummy Trial.
Hsu PI; Wu DC; Tsay FW; Cheng JS; Liu CP; Lai KH; Chen WC; Wang HM; Tsai TJ; Tsai KW; Kao SS
Am J Gastroenterol; 2017 Feb; 112(2):282-289. PubMed ID: 27922030
[TBL] [Abstract][Full Text] [Related]
4. A Randomized, Double-Blind, Pilot Study of the Effect of Famotidine on Acotiamide Treatment for Functional Dyspepsia.
Hojo M; Nagahara A; Asaoka D; Takeda T; Izumi K; Matsumoto K; Ueyama H; Shimada Y; Matsumoto K; Nojiri S; Watanabe S
Digestion; 2017; 96(1):5-12. PubMed ID: 28605740
[TBL] [Abstract][Full Text] [Related]
5. Famotidine for the prevention of peptic ulcers and oesophagitis in patients taking low-dose aspirin (FAMOUS): a phase III, randomised, double-blind, placebo-controlled trial.
Taha AS; McCloskey C; Prasad R; Bezlyak V
Lancet; 2009 Jul; 374(9684):119-25. PubMed ID: 19577798
[TBL] [Abstract][Full Text] [Related]
6. Comparison of PPIs and H2-receptor antagonists plus prokinetics for dysmotility-like dyspepsia.
Sakaguchi M; Takao M; Ohyama Y; Oka H; Yamashita H; Fukuchi T; Ashida K; Murotani M; Murotani M; Majima K; Morikawa H; Hashimoto T; Kiyota K; Esaki H; Amemoto K; Isowa G; Takao F
World J Gastroenterol; 2012 Apr; 18(13):1517-24. PubMed ID: 22509084
[TBL] [Abstract][Full Text] [Related]
7. A randomized clinical trial of histamine 2 receptor antagonism in treatment-resistant schizophrenia.
Meskanen K; Ekelund H; Laitinen J; Neuvonen PJ; Haukka J; Panula P; Ekelund J
J Clin Psychopharmacol; 2013 Aug; 33(4):472-8. PubMed ID: 23764683
[TBL] [Abstract][Full Text] [Related]
8. Effects of famotidine, mosapride and tandospirone for treatment of functional dyspepsia.
Kinoshita Y; Hashimoto T; Kawamura A; Yuki M; Amano K; Sato H; Adachi K; Sato S; Oshima N; Takashima T; Kitajima N; Abe K; Suetsugu H
Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():37-41. PubMed ID: 15943845
[TBL] [Abstract][Full Text] [Related]
9. Maintenance treatment is not necessary after Helicobacter pylori eradication and healing of bleeding peptic ulcer: a 5-year prospective, randomized, controlled study.
Liu CC; Lee CL; Chan CC; Tu TC; Liao CC; Wu CH; Chen TK
Arch Intern Med; 2003 Sep; 163(17):2020-4. PubMed ID: 14504114
[TBL] [Abstract][Full Text] [Related]
10. Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs.
Taha AS; Hudson N; Hawkey CJ; Swannell AJ; Trye PN; Cottrell J; Mann SG; Simon TJ; Sturrock RD; Russell RI
N Engl J Med; 1996 May; 334(22):1435-9. PubMed ID: 8618582
[TBL] [Abstract][Full Text] [Related]
11. Famotidine in the treatment of functional dyspepsia: a randomized double-blind, placebo-controlled trial.
Amini M; Ghamar Chehreh ME; Khedmat H; Valizadegan G; Babaei M; Darvishi A; Taheri S
J Egypt Public Health Assoc; 2012 Apr; 87(1-2):29-33. PubMed ID: 22415333
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and pharmacodynamics of famotidine in paediatric patients.
James LP; Kearns GL
Clin Pharmacokinet; 1996 Aug; 31(2):103-10. PubMed ID: 8853932
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the efficacy of irsogladine maleate and famotidine for the healing of gastric ulcers after Helicobacter pylori eradication therapy: a randomized, controlled, prospective study.
Murakami K; Okimoto T; Kodama M; Tanahashi J; Mizukami K; Shuto M; Abe H; Arita T; Fujioka T
Scand J Gastroenterol; 2011 Mar; 46(3):287-92. PubMed ID: 21073372
[TBL] [Abstract][Full Text] [Related]
14. [FAMOTIDINE VERSUS PLACEBO IN NON ULCER DYSPEPSIA TREATMENT].
Cahuayme L; Berríos J; Recavarren S; Huerta Mercado J; Bussalleu A
Rev Gastroenterol Peru; 2000; 20(3):213-228. PubMed ID: 12140583
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic effects of famotidine on chronic symptomatic gastritis: subgroup analysis from FUTURE study.
Kinoshita Y; Chiba T;
J Gastroenterol; 2012 Apr; 47(4):377-86. PubMed ID: 22183857
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological interventions for recurrent abdominal pain (RAP) and irritable bowel syndrome (IBS) in childhood.
Huertas-Ceballos A; Logan S; Bennett C; Macarthur C
Cochrane Database Syst Rev; 2008 Jan; (1):CD003017. PubMed ID: 18254013
[TBL] [Abstract][Full Text] [Related]
17. [Double-blind controlled-clinical trials of lansoprazole in the treatment of peptic ulcer].
Ogawa N
Nihon Rinsho; 1992 Jan; 50(1):68-73. PubMed ID: 1347332
[TBL] [Abstract][Full Text] [Related]
18. Similar Efficacy of Proton-Pump Inhibitors vs H2-Receptor Antagonists in Reducing Risk of Upper Gastrointestinal Bleeding or Ulcers in High-Risk Users of Low-Dose Aspirin.
Chan FK; Kyaw M; Tanigawa T; Higuchi K; Fujimoto K; Cheong PK; Lee V; Kinoshita Y; Naito Y; Watanabe T; Ching JY; Lam K; Lo A; Chan H; Lui R; Tang RS; Sakata Y; Tse YK; Takeuchi T; Handa O; Nebiki H; Wu JC; Abe T; Mishiro T; Ng SC; Arakawa T
Gastroenterology; 2017 Jan; 152(1):105-110.e1. PubMed ID: 27641510
[TBL] [Abstract][Full Text] [Related]
19. Famotidine treatment of children with autistic spectrum disorders: pilot research using single subject research design.
Linday LA; Tsiouris JA; Cohen IL; Shindledecker R; DeCresce R
J Neural Transm (Vienna); 2001; 108(5):593-611. PubMed ID: 11459079
[TBL] [Abstract][Full Text] [Related]
20. Clinical evaluation of the effect of omeprazole, cimetidine, famotidine and ranitidine on histamine induced cutaneous wheal and flare response.
Saha N; Sachdev A; Bhasin DK; Sankaranahyanan A; Khosla PP; Singh K; Sharma PL
Int J Clin Pharmacol Ther Toxicol; 1993 Jul; 31(7):322-5. PubMed ID: 8103763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
